ILMN·Nasdaq·US

Illumina

Illumina develops, manufactures, and sells next-generation sequencing systems, consumables, microarrays, and related software and services for genomic analysis. Its business is driven primarily by recurring consumable revenue from sequencing workflows, with additional revenue from instrument sales and clinical and research applications.

Create free account

Thematic Position

ILMN

Healthcare Innovation

AI Drug Discovery

Medical Devices

Relationship Groups

Customers9

Partners5

Licensing5

Competitors8

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

sanctionexport controlarmed conflict

U.S. and allied-country sanctions and export restrictions prohibit Illumina shipments to Russia

SEC 10-KFeb 12, 2026

The full regulatory passage is part of the Pro plan.

16 more · Regulatory and geopolitical insights are part of the Pro plan.

Related Events

1 event · Related events are part of the Pro plan.